Latest News
Gustavo A. Angarita, MD, MHS; Joao P. De Aquino, MD; Matthew Girgenti, PhD; Elizabeth Goldfarb, PhD; and Rajiv Radhakrishnan, MD, have been elected to Associate Membership of the American College of Neuropsychopharmacology.
- December 09, 2024Source: The New York Times
Gerard Sanacora, MD, PhD, George D. and Esther S. Gross Professor of Psychiatry, spoke to The New York Times about some common questions and misconceptions about antidepressants. Sanacora is director of the Yale Depression Research Program.
- October 24, 2024Source: Yale Medicine
A Yale psychiatrist answers questions about electroconvulsive therapy (ECT), a psychiatric treatment that involves sending electrical currents through the brain.
- October 02, 2024
A small sample of patients with bipolar disorder displayed noteworthy improvement in their depressive symptoms after being treated with the rapid-acting antidepressant intravenous ketamine and the nasal spray esketamine, according to a new Yale led-study. Mia Santucci, BA, postgraduate associate, and Samuel Wilkinson, MD, associate professor of psychiatry, are lead and senior authors, respectively.
- August 20, 2024Source: The Wall Street Journal
Gerard Sanacora, MD, PhD, George D. and Esther S. Gross Professor of Psychiatry, spoke to The Wall Street Journal about ketamine's effect on the brain and why it can work as an antidepressant.
- May 20, 2024
Announcing the winners of the 2024 Yale School of Medicine teaching awards.
- May 02, 2024Source: The New England Journal of Medicine
Gerard Sanacora, MD, PhD, George D. and Esther S. Gross Professor of Psychiatry; and Sina Nikayin, MD, assistant professor of psychiatry, are featured in the first episode of a four-part Double Take video miniseries on depression from the New England Journal of Medicine.
- April 22, 2024Source: Yale Medicine
Ebony Dix, MD, assistant professor of psychiatry, spoke to Yale Medicine about treating patients who suffer from Long COVID, which physicians say is difficult to diagnose.
- April 03, 2024Source: Psychology Today
Samuel Wilkinson, MD, associate professor of psychiatry and associate director of the Yale Depression Research Program, writes in Psychology Today about the history of ketamine, its use to treat depression, and how it compares to esketamine.
- April 02, 2024Source: Molecular Psychiatry
Henrique Oliva, MD, PhD, postdoctoral associate; Gustavo A. Angarita, MD, MHS, assistant professor of psychiatry, and Yale colleagues conducted comprehensive meta-analysis on spine density as it relates to substance use. The findings were published in Molecular Psychiatry.